Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for non-motor symptoms in Parkinson's disease
Johan Marinus, Kangdi Zhu, Connie Marras, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 6, pp. 559-568
Open Access | Times Cited: 282

Showing 1-25 of 282 citing articles:

Parkinson disease-associated cognitive impairment
Dag Aarsland, Lucia Batzu, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 779
The Role of Movement Analysis in Diagnosing and Monitoring Neurodegenerative Conditions: Insights from Gait and Postural Control
Christopher Buckley, Lisa Alcock, Ríona Mc Ardle, et al.
Brain Sciences (2019) Vol. 9, Iss. 2, pp. 34-34
Open Access | Times Cited: 161
The neuropsychiatry of Parkinson's disease: advances and challenges
Daniel Weintraub, Dag Aarsland, К. Ray Chaudhuri, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 89-102
Open Access | Times Cited: 161
Understanding and approaching excessive daytime sleepiness
Laura Pérez‐Carbonell, Emmanuel Mignot, Guy Leschziner, et al.
The Lancet (2022) Vol. 400, Iss. 10357, pp. 1033-1046
Closed Access | Times Cited: 130
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
Dongdong Zhang, Sheng Li, Liyan Hou, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 113
Clinical and imaging evidence of brain-first and body-first Parkinson's disease
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 96
Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment
Stéphane Prange, Hélène Klinger, Chloé Laurencin, et al.
Drugs & Aging (2022) Vol. 39, Iss. 6, pp. 417-439
Open Access | Times Cited: 85
Parkinson's Disease: A Multisystem Disorder
Helena Nunes Costa, A. Raquel Esteves, Nuno Empadinhas, et al.
Neuroscience Bulletin (2022) Vol. 39, Iss. 1, pp. 113-124
Closed Access | Times Cited: 83
The validity and reliability of the PHQ-9 on screening of depression in neurology: a cross sectional study
Yajing Sun, Zhifei Kong, Yuqing Song, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 70
Sleep and wakefulness disturbances in Parkinson's disease: A meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia
Gianpaolo Maggi, Carmine Vitale, Francesco Cerciello, et al.
Sleep Medicine Reviews (2023) Vol. 68, pp. 101759-101759
Closed Access | Times Cited: 55
Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease
Stephanie Martins de Faria, Daiene de Morais Fabrício, Vítor Tumas, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 2, pp. 189-196
Closed Access | Times Cited: 105
Young Onset Parkinson’s Disease: A Modern and Tailored Approach
Bart Post, Lieneke van den Heuvel, Teije van Prooije, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. s1, pp. S29-S36
Open Access | Times Cited: 91
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease
Vasiliki Orgeta, Kathryn McDonald, Ellen Poliakoff, et al.
Cochrane library (2020) Vol. 2020, Iss. 2
Open Access | Times Cited: 90
Sequence of clinical and neurodegeneration events in Parkinson’s disease progression
Neil P. Oxtoby, Louise‐Ann Leyland, Leon M. Aksman, et al.
Brain (2021) Vol. 144, Iss. 3, pp. 975-988
Open Access | Times Cited: 79
<p>Impact of non-motor symptoms in Parkinson’s disease: a PMDAlliance survey</p>
Neal Hermanowicz, Sarah Jones, Robert A. Hauser
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 2205-2212
Open Access | Times Cited: 77
Parkinson disease-associated cognitive impairment

Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 75
A comprehensive review on the applications of nano-biosensor-based approaches for non-communicable and communicable disease detection
Rout George Kerry, Kingsley Eghonghon Ukhurebor, Swati Kumari, et al.
Biomaterials Science (2021) Vol. 9, Iss. 10, pp. 3576-3602
Closed Access | Times Cited: 68
Treatment of Parkinson’s Disease with Cognitive Impairment: Current Approaches and Future Directions
Chichun Sun, Melissa J. Armstrong
Behavioral Sciences (2021) Vol. 11, Iss. 4, pp. 54-54
Open Access | Times Cited: 63
Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study
Valérie Cochen De Cock, Pauline Dodet, Smaranda Leu‐Semenescu, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 5, pp. 428-437
Open Access | Times Cited: 54
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
Paola Imbriani, Giuseppina Martella, Paola Bonsi, et al.
Neurobiology of Disease (2022) Vol. 173, pp. 105851-105851
Open Access | Times Cited: 39
Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study
Tingting Liu, Hongzhou Zuo, Di Ma, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Machine Learning in the Parkinson’s disease smartwatch (PADS) dataset
Julian Varghese, Alexander Brenner, Michael Fujarski, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Acupuncture and Sleep Quality Among Patients With Parkinson Disease
Mingyue Yan, Jingqi Fan, Xin Liu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2417862-e2417862
Open Access | Times Cited: 9
Managing cognitive impairment in Parkinson’s disease: an update of the literature
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access | Times Cited: 1
Parkinson's Disease Dementia and Lewy Body Disease
Mi̇ne Sezgi̇n, Başar Bılgıç, Sule Tinaz, et al.
Seminars in Neurology (2019) Vol. 39, Iss. 02, pp. 274-282
Closed Access | Times Cited: 59
Page 1 - Next Page

Scroll to top